Discover and read the best of Twitter Threads about #ScienceWillWin
Most recents (4)
CEO of Pfizer Albert Bourla wrote a book called Moonshot will share some interesting parts.
Slogan they pushed for their rushed vaccine #ScienceWillWin
Slogan they pushed for their rushed vaccine #ScienceWillWin
Bourla describes being very impressed by VP Pence, in contrast to Trump who he states he didn't trust and was not in contact.
Pfizer's rushed vaccine project called "Light Speed" not directly tied to Trump's "Warp Speed." Hmm
Pfizer's rushed vaccine project called "Light Speed" not directly tied to Trump's "Warp Speed." Hmm
In each vial was it 6 or 7 doses?
Dr. Bourla answers 6.6
Edit by The Karen Archipelago
Dr. Bourla answers 6.6
Edit by The Karen Archipelago
Shout out to participants in #clinicaltrials. I’m enrolled in an NIH RADx-supported trial that requires me to do #COVID19 rapid tests & PCR every other day within a time window, & then drive a pkg to a FedEx every other day by 3p. This is the 4th study I’ve joined in my life…
The studies I’ve been in have ranged from pregnancy outcomes yrs ago to #COVID19 diagnostics. I keep joining them because I believe #ScienceWillWin, but also because it’s important to be reminded what a genuine hassle it is to be in a study. /2
In the very best of circumstances, it’s an inconvenience. It ALWAYS costs participants something, whether it’s missed work, lost wages, childcare, gas for a 🚗, discomfort, or more. And it’s always one more thing in a day that may already have way too many things already (🙋🏻♀️). /3
#Pfizer has mRNA flu vaccine as a "key development readout" for 2022.
You know what that means. Probably nothing. @RWMaloneMD
You know what that means. Probably nothing. @RWMaloneMD
More details in the press release. Who could have thought that Covid is just the beginning!
pfizer.com/news/press-rel…
pfizer.com/news/press-rel…
Very happy to say that we have more good news to share. The final efficacy analysis of @Pfizer's Phase 3 study showed that our #COVID19 vaccine candidate met all of the study's primary efficacy endpoints: pfizer.com/news/press-rel…
Most notably, the vaccine candidate was shown to be 95% effective in helping prevent #COVID19 beginning 28 days after the first dose.
We also announced that the safety database required by the @US_FDA for Emergency Use Authorization (EUA) has been achieved.
